1Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology Guidelines for the management of arterial hypertension [ J ]. Hypertens, 2003,21:1011 - 1053.
3The Task for the Management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension [ J ]. Hypertens ,2007,25 : 1105 - 1187.
4Nichols WW, ORourke M. McDonald's blood flow in arteries: theoretical, experimental and clinical principles [ M]. London UK:Amold,2005.
5Mitchell GF, Lacourciere Y, Ouellet JP, et al. Determinants of elevated pulse pressure in middle - aged and other subjects with uncomplicated systolic hypertension: the role of proximal apostolic diameter and the aortic pressure - flow relationship [ J ]. Circulation, 2003, 108 : 1592 - 1598.
6Sawabe M, Takahashi R, Matsushita S, et al. Aortic pulse wave velocity and the degree of arteriosclerosis in the elderly a pathological study based on 304 autopsy - cases[J]. Arteriosclerosis ,2005,179:345 - 351.
7Cattan V, Kakou A, Louis H. Pathophysiology, genetic, and therapy of arterial stiffness [ J ]. Biomed Mater Eng,2006,16 : 155 - 161.
10Agabiti R J, Mancia G, O' Rourke MF, et al. Central blood pressure measurements and antihypertensive therapy: a consensus document [ J ]. Hypertension, 2007,50 (1):154-160.
二级参考文献19
1Nunez E.Arnett DK.Benjamin EJ,et al.Comparison of the prog nostic value of left ventricular hypertrophy in African-American men versus women.Am J Cardiol.2004,94(11):1383-1390.
2叶任高,陆再英.内科学.5版.北京:人民卫生出版社,2000,258-270.
3Devereuz R.Alonso D.Lutes E.et al.Echocardiographic assessment of left ventricular hypertrophy:comparison to necropsy findings.Am J Cardiol,1986,57:450-458.
4Zakynthinos E.Pierutsakos C,Konstantinidis K.et al.Losartan reduces left ventricular hypertrophy proprtionally to blood pressure reduction in hypertensivcs.but does not affect diastolic cardiac function.Angiology,2004,55(6):669-678.
5Chen Huan C，Circulation，1997年，95卷，7期，1827页
6Ting C T，Hypertension，1995年，25卷，1326页
7Avolio A P，Circulation，1985年，71卷，202页
8Dahlof B,Devereaux RB,Kjeldsen SE,et al.Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint Reduction in Hypertension Study(LIFE):a randomised trial against atenolol[J].Lancet,2002,359:995-1003.
9Dahlof B,Sever PS,Poulter NR,et al.Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required,in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm(ASCOT-BPLA):a multicentre randomized trial[J].Lancet,2005,366:895-906.
10Williams B,Lacy PS,Thom SM,et al.Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes:principal results of the Conduit Artery Function Evaluation(CAFE)study[J].Circulation,2006,113:1213-1225.
